GA
EW icon

GraniteShares Advisors’s Edwards Lifesciences EW Stock Holding History

GraniteShares Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$684K Sell
8,547
-1,398
-14% -$115K 0.49% 62
2025
Q4 		$848K Buy
9,945
+443
+5% +$36.4K 0.51% 62
2025
Q3 		$739K Buy
9,502
+172
+2% +$13.4K 0.43% 69
2025
Q2 		$730K Sell
9,330
-509
-5% -$38K 0.45% 69
2025
Q1 		$713K Sell
9,839
-515
-5% -$36.9K 0.45% 65
2024
Q4 		$767K Sell
10,354
-2,132
-17% -$149K 0.49% 66
2024
Q3 		$824K Buy
12,486
+1,399
+13% +$102K 0.56% 67
2024
Q2 		$1.02M Buy
11,087
+1,091
+11% +$96.6K 0.34% 60
2024
Q1 		$955K Sell
9,996
-597
-6% -$50.1K 0.51% 65
2023
Q4 		$808K Sell
10,593
-825
-7% -$57.4K 0.73% 65
2023
Q3 		$791K Buy
+11,418
New +$918K 0.74% 64
2022
Q3 		– Sell
-2,358
Closed -$224K – 139
2022
Q2 		$224K Sell
2,358
-494
-17% -$51.1K 0.16% 132
2022
Q1 		$335K Sell
2,852
-93
-3% -$10.4K 0.18% 126
2021
Q4 		$381K Buy
+2,945
New +$344K 0.18% 127

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GraniteShares Advisors's EW Position: Q1 2026 in Review

GraniteShares Advisors reduced its Edwards Lifesciences (EW) stake by 14% in Q1 2026, selling an estimated $115K and leaving 8,547 shares worth $684K. The position accounts for 0.49% of the portfolio, ranked #62.

GraniteShares Advisors first reported a position in EW in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.02M in Q2 2024. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • GraniteShares Advisors held 8,547 shares of Edwards Lifesciences worth $684K as of Q1 2026.
  • GraniteShares Advisors sold 1,398 Edwards Lifesciences shares in Q1 2026, an estimated $115K.
  • Edwards Lifesciences made up 0.49% of GraniteShares Advisors's portfolio in Q1 2026, its #62 holding.
  • GraniteShares Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 14 quarters since.
  • GraniteShares Advisors's Edwards Lifesciences position peaked at $1.02M in Q2 2024.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on GraniteShares Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.